I know there is another thing required to get its cost benefit assessed so that the various nations health systems will approve its use over alternatives. (AKA similar to some drugs are cheap in Australia because they have been assesed as cost effective)
Anyway there are trials >being< done for that?
I thought they were re-analysing existing data and trying by means X or Y to statistically match those already treated cases to other similar cases treated with existing treatments and then doing the economics to show cost benefit. AKA formalisng and robustifying existing cost benefit stuff the shareholders were shown.
product trials, are happening?
TIS Price at posting:
22.0¢ Sentiment: Buy Disclosure: Held